American Medical Technologies Stock Current Valuation
| ADLI Stock | USD 0.0001 0.00 0.00% |
Valuation analysis of American Medical Tec helps investors to measure American Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The American Medical's current Enterprise Value Over EBITDA is estimated to increase to -2.31. The American Medical's current Enterprise Value Multiple is estimated to increase to -2.31. Fundamental drivers impacting American Medical's valuation include:
Overvalued
Today
Please note that American Medical's price fluctuation is very steady at this time. Calculation of the real value of American Medical Tec is based on 3 months time horizon. Increasing American Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since American Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of American Stock. However, American Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of American Medical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence American Medical's stock price.
Estimating the potential upside or downside of American Medical Technologies helps investors to forecast how American stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of American Medical more accurately as focusing exclusively on American Medical's fundamentals will not take into account other important factors: American Medical Technologies Company Current Valuation Analysis
American Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current American Medical Current Valuation | 482.09 K |
Most of American Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, American Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
American Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for American Medical is extremely important. It helps to project a fair market value of American Stock properly, considering its historical fundamentals such as Current Valuation. Since American Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of American Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of American Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, American Medical Technologies has a Current Valuation of 482.09 K. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 99.99% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
American Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses American Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of American Medical could also be used in its relative valuation, which is a method of valuing American Medical by comparing valuation metrics of similar companies.American Medical is currently under evaluation in current valuation category among its peers.
American Fundamentals
| Return On Asset | -0.17 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | (0.22) % | ||||
| Current Valuation | 482.09 K | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 2.5 M | ||||
| Gross Profit | 1.66 M | ||||
| EBITDA | (260.95 K) | ||||
| Net Income | 194.36 K | ||||
| Cash And Equivalents | 40.62 K | ||||
| Total Debt | 3384.32 T | ||||
| Current Ratio | 0.47 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (160.42 K) | ||||
| Number Of Employees | 12 | ||||
| Beta | -49.3 | ||||
| Market Capitalization | 25.97 K | ||||
| Total Asset | 1.53 M | ||||
| Working Capital | (1.1 M) | ||||
| Current Asset | 784 K | ||||
| Current Liabilities | 1.89 M | ||||
| Net Asset | 1.53 M |
About American Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze American Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of American Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of American Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether American Medical Tec offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of American Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of American Medical Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on American Medical Technologies Stock:Check out American Medical Piotroski F Score and American Medical Altman Z Score analysis. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of American Medical. If investors know American will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about American Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Revenue Per Share | Quarterly Revenue Growth (0.19) | Return On Assets |
The market value of American Medical Tec is measured differently than its book value, which is the value of American that is recorded on the company's balance sheet. Investors also form their own opinion of American Medical's value that differs from its market value or its book value, called intrinsic value, which is American Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because American Medical's market value can be influenced by many factors that don't directly affect American Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between American Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if American Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, American Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.